Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario.

Authors:
Zhao M; Zhang Y; Chen L; Yan X; Xu T and 10 more

Journal:
Front Cell Infect Microbiol

Publication Year: 2024

DOI:
10.3389/fcimb.2024.1330788

PMCID:
PMC10861792

PMID:
38352054

Journal Information

Full Title: Front Cell Infect Microbiol

Abbreviation: Front Cell Infect Microbiol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the datasets of nanopore sequencing for this study have been deposited into cngb sequence archive (cnsa) of china national genebank database (cngbdb) with accession number cnp0004703."

Code Sharing
Evidence found in paper:

"Conflict of interest Authors DS and SL were employed by the company Dian Diagnostics Group Co., Ltd. and Nanjing Dian Diagnostics Group Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by a grant from Horizontal Project Fund of Soochow University (No. SDKY20211200)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025